Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp & dohme ireland (human health) limited - losartan potassium - film coated tablet - 100 milligram - angiotensin ii antagonists, plain

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratorios liconsa, s.a. - losartan potassium hydrochlorothiazide - film coated tablet - 100/25 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratorios liconsa, s.a. - losartan potassium hydrochlorothiazide - film coated tablet - 50/12.5 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - losartan potassium - film coated tablet - 12.5 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - losartan potassium - film coated tablet - 25 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

milpharm limited - losartan potassium - film coated tablet - 50 milligram - angiotensin ii antagonists, plain

Ireland - English - HPRA (Health Products Regulatory Authority)

milpharm limited - losartan potassium - film coated tablet - 100 milligram - angiotensin ii antagonists, plain

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

krka d.d. novo mesto d.d. - losartan potassium 12,5 mg - eq. losartan 11,45 mg - film-coated tablet - 12,5 mg - losartan potassium 12.5 mg - losartan

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - losartan potassium, quantity: 25 mg - tablet, film coated - excipient ingredients: magnesium stearate; pregelatinised maize starch; lactose monohydrate; microcrystalline cellulose; titanium dioxide; hypromellose; hyprolose - hypertension: cozavan is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents (e.g. thiazide diuretics). renal protection in type 2 diabetic patients with proteinuria: cozavan is indicated to delay the progression of renal disease in hypertensive type 2 diabetics with proteinuria, defined as urinary albumin to creatinine ratio greater than or equal to 300mg/g.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - losartan potassium, quantity: 50 mg - tablet, film coated - excipient ingredients: lactose monohydrate; pregelatinised maize starch; microcrystalline cellulose; magnesium stearate; titanium dioxide; hypromellose; hyprolose - hypertension: cozavan is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents (e.g. thiazide diuretics). renal protection in type 2 diabetic patients with proteinuria: cozavan is indicated to delay the progression of renal disease in hypertensive type 2 diabetics with proteinuria, defined as urinary albumin to creatinine ratio greater than or equal to 300mg/g.